Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 2 ( February, 2021 ) > List of Articles

LETTER TO EDITOR

Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management

Keywords : COVID-19, Coronavirus disease, Pulmonary fibrosis, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2

Citation Information : Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management. Indian J Crit Care Med 2021; 25 (2):242-244.

DOI: 10.5005/jp-journals-10071-23733

License: CC BY-NC 4.0

Published Online: 22-02-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res 2020;8:8. DOI: 10.1038/s41413-020-0084-5.
  2. Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, et al. Follow up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging 2017;27(3):342–349. DOI: 10.4103/ijri.IJRI_469_16.
  3. Lee N, Hui D, Wu A, Chan P, Cameron P, Joyn GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348(20):1986–1994. DOI: 10.1056/NEJMoa030685.
  4. Chiang CH, Shih JF, Su WJ, Perng RP. Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome. Mayo Clin Proc 2004;79(11):1372–1379. DOI: 10.4065/79.11.1372.
  5. Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, et al. Chronology of histological lesions in acute respiratory distress syndrome with diff use alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 2013;1(5):395–401. DOI: 10.1016/S2213-2600(13)70053-5.
  6. Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R. Lung fibrosis: an undervalued finding in COVID-19 pathological series [published online ahead of print, 2020 Jul 28]. Lancet Infect Dis 2020. DOI: 10.1016/S1473-3099(20)30582-X.
  7. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020;55(6):2001217. DOI: 10.1183/13993003.01217-2020.
  8. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020;8(8):807–815. DOI: 10.1016/S2213-2600(20)30225-3.
  9. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377(9779):1760–1769. DOI: 10.1016/S0140-6736(11)60405-4.
  10. Fois AG, Posadino AM, Giordo R, Cossu A, Agouni A, Rizk NM, et al. Antioxidant activity mediates pirfenidone antifibrotic effects in human pulmonary vascular smooth muscle cells exposed to sera of idiopathic pulmonary fibrosis patients. Oxid Med Cell Longev 2018;2018:2639081. DOI: 10.1155/2018/2639081.
  11. Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 2019;381(18):1718–1727. DOI: 10.1056/NEJMoa1908681.
  12. Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, et al. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun 2019;10(1):6. DOI: 10.1038/s41467-018-07858-8 [Erratum in: Nat Commun. 2020;11(1):4680].
  13. Mora AL, Rojas M, Pardo A, Selman M. Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. Nat Rev Drug Discov 2017;16(11):810. DOI: 10.1038/nrd.2017.225.
  14. Raghu G, Van Den Blink B, Hamblin MJ, Whitney Brown A, Golden JA, Ho LA, et al. Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis a randomized clinical trial. JAMA 2018;319(22):2299–2307. DOI: 10.1001/jama.2018.6129.
  15. British Thoracic Society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia. [Internet]. Brit-thoracic.org.uk. 2020 [cited 15 September 2020]. Available at: https://www.brit-thoracic.org.uk/about-us/covid-19-information-for-the-respiratory- community.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.